10-K Decoder · All companies

Cartesian Therapeutics, Inc.

RNAC · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$2.80M$38.9M−92.8%
Operating income−$143M−$43.9M−227%
Net income−$130M−$77.4M−68.3%

Questions

What was Cartesian Therapeutics's revenue in FY2025?
$2.80M in FY2025 (Fiscal year ended Dec 31, 2025), −92.8% vs $38.9M a year earlier, per its 10-K filed Mar 2026.
Was Cartesian Therapeutics profitable in FY2025?
No: net income was −$130M and operating income −$143M in FY2025.